Granules India Ltd
NSE:GRANULES

Watchlist Manager
Granules India Ltd Logo
Granules India Ltd
NSE:GRANULES
Watchlist
Price: 607.35 INR -0.59% Market Closed
Market Cap: 147.4B INR

Relative Value

The Relative Value of one GRANULES stock under the Base Case scenario is hidden INR. Compared to the current market price of 607.35 INR, Granules India Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GRANULES Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
14
vs Industry
42
Median 3Y
2.5
Median 5Y
2.4
Industry
2.6
Forward
2.8
vs History
7
vs Industry
18
Median 3Y
25
Median 5Y
19.1
Industry
21.4
Forward
25
vs History
65
vs Industry
28
Median 3Y
16.2
Median 5Y
17.3
Industry
16.4
vs History
84
vs Industry
5
Median 3Y
34.8
Median 5Y
46.3
Industry
22.8
vs History
20
vs Industry
21
Median 3Y
3.3
Median 5Y
3.3
Industry
2.2
vs History
7
vs Industry
40
Median 3Y
2.6
Median 5Y
2.5
Industry
2.9
Forward
2.9
vs History
22
vs Industry
43
Median 3Y
4.6
Median 5Y
4.5
Industry
5.5
vs History
4
vs Industry
28
Median 3Y
13.2
Median 5Y
11.4
Industry
13
Forward
13.6
vs History
4
vs Industry
26
Median 3Y
17.2
Median 5Y
14.4
Industry
16.5
Forward
18.4
vs History
57
vs Industry
28
Median 3Y
16.3
Median 5Y
17.3
Industry
15.6
vs History
33
vs Industry
14
Median 3Y
42.4
Median 5Y
42.9
Industry
18.7
vs History
11
vs Industry
27
Median 3Y
2.5
Median 5Y
2.5
Industry
1.9

Multiples Across Competitors

GRANULES Competitors Multiples
Granules India Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Granules India Ltd
NSE:GRANULES
147.3B INR 3 28.7 15.4 20.7
US
Eli Lilly and Co
NYSE:LLY
1.1T USD 17.7 57.3 38.6 41.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
500.7B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
269.6B CHF 4.4 28.6 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
221.5B GBP 5.1 31.6 108.8 159.3
CH
Novartis AG
SIX:NOVN
219.5B CHF 4.9 19.1 12.1 15.6
US
Merck & Co Inc
NYSE:MRK
277.7B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.8 11 12.8
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.7B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
IN
Granules India Ltd
NSE:GRANULES
Average P/E: 25.6
28.7
23%
1.2
US
Eli Lilly and Co
NYSE:LLY
57.3
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.6
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.6
37%
0.9
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
15.8
3%
5.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Granules India Ltd
NSE:GRANULES
Average EV/EBITDA: 401.6
15.4
20%
0.8
US
Eli Lilly and Co
NYSE:LLY
38.6
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
12.1
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Granules India Ltd
NSE:GRANULES
Average EV/EBIT: 1 714.5
20.7
22%
0.9
US
Eli Lilly and Co
NYSE:LLY
41.4
36%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.3
23%
6.9
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5